<DOC>
	<DOCNO>NCT02253550</DOCNO>
	<brief_summary>This study look safety efficacy 8 week 12 week treatment Sofosbuvir Simeprevir treatment-naïve treatment-experienced patient chronic hepatitis C genotype 4 .</brief_summary>
	<brief_title>Simeprevir Combination With Sofosbuvir Treatment-Naïve -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection</brief_title>
	<detailed_description>Patients confirm absence cirrhosis receive 8 week treatment Sofosbuvir Simeprevir . Patients confirm presence cirrhosis receive 12 week treatment Sofosbuvir Simeprevir . All patient follow 24 week post-treatment . Presence absence cirrhosis evaluate FibroScan historical liver biopsy FibroScan available .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>HCV genotype 4 infection HCV RNA &gt; 10,000 IU/mL screening . Evidence clinical hepatic decompensation ( history current evidence ascites , bleed varix hepatic encephalopathy ) . Any liver disease nonHCV etiology . This include , limited , acute hepatitis A , drug alcoholrelated liver disease , autoimmune hepatitis , hemochromatosis , Wilson 's disease , alpha1 antitrypsin deficiency , nonalcoholic steatohepatitis , primary biliary cirrhosis , nonHCV liver disease consider clinically significant investigator . Infection/coinfection HCV nongenotype 4 . Coinfection human immunodeficiency virus ( HIV ) type 1 type 2 ( HIV1 HIV2 ) ( positive HIV1 HIV2 antibodies test screen ) . Coinfection hepatitisB virus ( hepatitisBsurfaceantigen [ HBsAg ] positive ) . Presence significant comorbidities condition would compromise subject 's safety could interfere subject 's participation full duration study opinion investigator Previously treat direct act antiHCV agent ( approved investigational ) chronic HCV infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>